| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 127852-31-7 | (R)-3-(1-Aminoethyl)benzonitrile | C9H10N2 |
| 127862-89-9 | (alphaS)-alpha-[[(Phenylmethoxy)carbonyl]amino]benzenebutanoic acid | C18H19NO4 |
| 127869-51-6 | Human C-type natriuretic peptide(1-22);C-Type natriuretic factor-22 (pig); Human C-type natriuretic peptide(1-22); Human CNP-22; Porcine C-type natriuretic peptide(1-22); Rat C-type natriuretic peptide(1-22) | C93H157N27O28S3 |
| 127892-62-0 | 4-Chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxylic acid | C7H9ClN2O2 |
| 127910-31-0 | (3E)-2-Amino-4-methyl-5-phosphono-3-pentenoic acid;CGP 37849 | C6H12NO5P |
| 127913-44-4 | (S)-4-Chloro-3-hydroxybutyronitrile | C4H6ClNO |
| 127919-28-2 | Ethyl 5-(4-chlorophenyl)oxazole-4-carboxylate | C12H10ClNO3 |
| 127926-65-2 | 9,9-Bis(3-fluoro-4-aminophenyl)fluorene;9,9-Bis(4-amino-3-fluorophenyl)fluorene | C25H18F2N2 |
| 127942-30-7 | Ethyl 2-aminothiazole-4-carboxylate hydrobromide;2-Aminothiazole-4-carboxylic acid ethyl ester hydrobromide; 2-Aminothiazole-4-carboxylic acid ethyl ester monohydrobromide | C6H8N2O2S.HBr |
| 127946-77-4 | 1-Amino-1-cyclopropanecarbonitrile hydrochloride | C4H7ClN2 |
| 127955-44-6 | Erythromycin EP Impurity L;N-[(2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-N-methylformamide | C37H65NO14 |
| 127958-08-1 | 4-Isopropyl-2-methylpyrimidine-5-carboxylic acid | C9H12N2O2 |
| 127971-24-8 | 1-Cyclopropyl-4-bromonaphthalene;1-bromo-4-cyclopropylnaphthalene | C13H11Br |
| 127972-00-3 | 2-Methoxy-5-methylphenylboronic acid;(2-Methoxy-5-methylphenyl)boronic acid | C8H11BO3 |
| 127972-02-5 | 2-Methoxy-5-formylphenylboronic acid;5-Formyl-2-methoxyphenylboronic acid | C8H9BO4 |
| 127978-70-5 | (5-Methoxy-2-pyridyl)methanol;(5-Methoxypyridin-2-yl)methanol; 2-(Hydroxymethyl)-5-methoxypyridine | C7H9NO2 |
| 127984-74-1 | Lanreotide acetate;BIM 23014C; Lanreotide acetate; Somatulina; Somatuline | C54H69N11O10S2.x(C2H4O2) |
| 127986-84-9 | (S)-(-)-Di-(2-naphthyl)-2-pyrrolidinemethanol;(S)-Di-2-Naphthylprolinol | C25H23NO |
| 128008-30-0 | Indium(III) trifluoromethanesulfonate | C3F9InO9S3 |
| 128018-44-0 | (2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane;(2S,3S)-1,2-Epoxy-3-(benzyloxycarbonyl-amino)-4-phenylbutane | C18H19NO3 |
| 128019-59-0 | N-4-Boc-2-piperazinecarboxylic acid;4-(tert-Butoxylcarbonyl)-piperazine-2-carboxylic acid | C10H18N2O4 |
| 128052-92-6 | (1S,2R)-(+)-2-Amino-1-cyclopentanecarboxylic acid hydrochloride;(1S,2R)-Cispentacin hydrochloride | C6H11NO2.HCl |
| 128055-74-3 | 2,2',7,7'-Tetrabromo-9,9'-spirobifluorene | C25H12Br4 |
| 128071-75-0 | 2-Bromopyridine-3-carbaldehyde;2-Bromonicotinaldehyde | C6H4BrNO |
| 128071-79-4 | 4-Bromo-2-fluoro-3-methylpyridine | C6H5BrFN |
| 128071-86-3 | 4-Bromo-2-chloro-3-methylpyridine | C6H5BrClN |
| 128071-88-5 | 1-(4-Bromo-2-chloropyridin-3-yl)ethanol;4-Bromo-2-chloro-alpha-methyl-3-pyridinemethanol | C7H7BrClNO |
| 128071-98-7 | 4-Bromo-2-fluoropyridine;2-Fluoro-4-bromopyridine | C5H3BrFN |
| 128072-93-5 | Ethyl 5-chloro-2-pyridinecarboxylate | C8H8ClNO2 |
| 128072-94-6 | 5-(Trifluoromethyl)-2-pyridinecarboxylic acid ethyl ester | C9H8F3NO2 |
| 128073-16-5 | 3-Chloro-5-trifluoromethylpyridine-2-carboxylic acid ethyl ester;Ethyl 3-chloro-5-(trifluoromethyl)-2-pyridinecarboxylate | C9H7ClF3NO2 |
| 128092-72-8 | (2-Fluorophenyl)(4-fluorophenyl)phenylmethanol;Flutrimazole carbinol | C19H14F2O |
| 128102-16-9 | (R)-1-Boc-4-Cbz-2-methylpiperazine;(R)-2-Methylpiperazine-1,4-dicarboxylic acid 4-benzyl ester 1-tert-butyl ester | C18H26N2O4 |
| 128102-80-7 | 2-Methylpyrido[2,3-b]pyrazin-3(4H)-one | C8H7N3O |
| 128107-47-1 | Fmoc-O-tert-butyl-D-serine;Fmoc-D-Ser(tBu)-OH; N-(9-fluorenylmethoxycarbonyl)-O-tert-butyl-D-serine | C22H25NO5 |
| 128117-22-6 | 3-Hydroxyazetidine-1-carboxylic acid benzyl ester;Phenylmethyl 3-hydroxyazetidine-1-carboxylate | C11H13NO3 |
| 128140-82-9 | 1-(Difluoromethoxy)-4-iodobenzene;4-(Difluoromethoxy)-1-iodobenzene | C7H5F2IO |
| 128143-89-5 | 4'-Chloro-2,2':6',2''-terpyridine;4'-Chloro-2,2,2':6',2''-terpyridine | C15H10ClN3 |
| 128146-85-0 | 3-Amino-5-methylisothiazole;5-Methyl-3-isothiazolamine | C4H6N2S |
| 128156-54-7 | 4-Benzoxazolecarboxylic acid methyl ester;Methyl 4-benzoxazolecarboxylate | C9H7NO3 |
| 128173-53-5 | (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt;(S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1) | 2(C20H23FN2O2).C20H18O8 |
| 128196-01-0 | Escitalopram;1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | C20H21FN2O |
| 128196-02-1 | (R)-Citalopram | C20H21FN2O |
| 128218-53-1 | 4-Methyl-7-(phosphonooxy)-2H-1-benzopyran-2-one compd. with cyclohexanamine (1:2) | C10H9O6P.2(C6H13N) |
| 128219-77-2 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-N-[(dimethylamino)methylene]-2'-O-methylguanosine 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] | C44H55N8O8P |
| 128219-81-8 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-phenoxyacetyl)adenosine | C40H39N5O8 |
| 128219-84-1 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methylinosine | C32H32N4O7 |
| 128219-85-2 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methylinosine 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] | C41H49N6O8P |
| 128249-70-7 | 2,6-Bis[(4R)-4-phenyl-2-oxazolinyl]pyridine;(R,R)-2,6-Bis(4,5-dihydro-4-phenyl-2-oxazolyl)pyridine; (R,R)-2,6-Bis(4-phenyl-2-oxazolinyl)pyridine; (+)-2,6-Bis[(4R)-4-phenyl-2-oxazolin-2-yl]pyridine | C23H19N3O2 |
| 128259-68-7 | 1,3-Dibromo-2,5-difluorobenzene | C6H2Br2F2 |